Compare Sangal Papers with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 7.00%
- Poor long term growth as Net Sales has grown by an annual rate of 11.11% over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 4.71 times
Flat results in Mar 26
38.76% of Promoter Shares are Pledged
Below par performance in long term as well as near term
Stock DNA
Paper, Forest & Jute Products
INR 24 Cr (Micro Cap)
10.00
16
0.00%
0.63
5.07%
0.50
Total Returns (Price + Dividend) 
Sangal Papers for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Sangal Papers Ltd Upgraded to Sell on Technical Improvement Despite Weak Fundamentals
Sangal Papers Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 6 August 2026, driven primarily by a shift in technical indicators despite persistent fundamental weaknesses. The micro-cap paper industry stock’s technical trend has improved from bearish to mildly bearish, prompting a reassessment of its near-term outlook. However, the company continues to face challenges in financial performance and valuation metrics, underscoring a cautious stance for investors.
Read full news article
Sangal Papers Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals
Sangal Papers Ltd has been downgraded from a Sell to a Strong Sell rating as of 3 August 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. The company’s micro-cap status, combined with flat financial performance and bearish market signals, has prompted a reassessment of its investment appeal across quality, valuation, financial trend, and technical parameters.
Read full news article
Sangal Papers Ltd Upgraded from Strong Sell to Sell on Technical Improvements
Sangal Papers Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook despite persistent fundamental challenges. The change, effective from 27 July 2026, is primarily driven by improvements in technical indicators, while valuation and financial trends remain subdued. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced this rating revision.
Read full news article Announcements 
Board Meeting Intimation for Board Meeting Intimation For Approval Of Un-Audited Results For The Quarter Ended On 30.06.2026.
31-Jul-2026 | Source : BSESangal Papers Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Sangal Papers Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026inter alia to consider and approve Unaudited Results for the quarter ended on 30.06.2026.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
04-Jul-2026 | Source : BSECertificate under Reg 74(5) of SEBI (DP) REGULATIONS 2018
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
04-Jul-2026 | Source : BSECertificate of RTA with Covering Letter under Reg 74(5) of SEBI ( DP) Regulations 2018
Corporate Actions 
13 Aug 2026
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Non Institution
38.7565
Held by 0 Schemes
Held by 0 FIIs
Amit Sangal (9.26%)
Mahendra Girdharilal Wadhwani (2.72%)
58.54%
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is -21.37% vs -3.41% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is 162.86% vs 16.67% in Dec 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 2.27% vs -2.40% in Sep 2024
Growth in half year ended Sep 2025 is -50.22% vs 384.78% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 6.87% vs -5.80% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -39.17% vs 49.07% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is -0.52% vs -5.29% in Mar 2025
YoY Growth in year ended Mar 2026 is -16.25% vs 14.57% in Mar 2025






